Clinical Trial Update: Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer

View source ↗

Summary

This completed clinical trial evaluates circulating tumor cells as a biomarker for preoperative prognostic staging in patients with resectable esophageal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Resectable Esophageal Cancer | Status: COMPLETED